Hall of Fame quarterback Brett Favre suffered a concussion on the last play of his career in 2010. Favre, who started a record 321 consecutive games spanning more than two decades, said that “probably 90 percent” of the tackles he endured resulted in some kind of concussion. RELATED STORIES Hoge & Jahns Podcast: What did […]
By JENNY VRENTAS November 07, 2017 On the last play of Brett Favre’s football career, he suffered a concussion. In the seven years since his retirement, the Hall of Fame quarterback has become increasingly honest regarding his concerns about the long-term consequences of the sport through which he made his name. There are times Favre will run into […]
The Prevacus story starts in Tallahassee, specifically at Florida High and Florida State University. Where the story ends is uncertain because nobody has all the answers concerning the long-term effects of concussions. However, the potentially groundbreaking drug could help change that. Prevacus is being developed by Jake VanLandingham, a neuroscientist and a former member of […]
Brett Favre had a 20-year career in the NFL, including an iron-man stint in which he played in 321 straight games. But it was his last play in the league that was a painful exclamation point on his illustrious tenure. In December 2010, while playing for the Vikings, the quarterback was sacked and knocked out […]
TALLAHASSEE, Fla., Feb. 22, 2017 (GLOBE NEWSWIRE) — Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders; today announced the addition of Steve Mariucci, Eddie DeBartolo Jr., Matt Hasselbeck and Warren Moon to its sports advisory board. “I am delighted to have the […]
TALLAHASSEE, Fla., Feb. 15, 2017 (GLOBE NEWSWIRE) — Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion (mild traumatic brain injury (mTBI)) and other neurological disorders; today announced that Dr. Jake VanLandingham and investor Brett Favre appeared on Fox Business’ “Mornings with Maria” on Friday, February 10, 2017 to discuss the Company’s […]
TALLAHASSEE, Fla., Feb. 09, 2017 (GLOBE NEWSWIRE) — Prevacus, Inc., a leading biopharmaceutical company focused on developing treatments for concussion aka mild Traumatic Brain Injury (mTBI) and other neurological disorders; today announced plans to initiate Phase 1 clinical studies of a novel treatment for concussion in humans. The Company expects to initiate its Phase 1 […]
The article featured in The Tallahassee Democrat (seen below) is a perfect example of the many ways Prevacus & it’s team want to help people and the community! Go Noles!
The infusion of new faculty at Florida State University — approximately 200 total professors over the past two years — is already paying off in terms of sponsored research. For the 2014 fiscal year that ended June 30, FSU faculty accumulated slightly more than $230 million in grants and contracts, the bulk of it from federal […]
Prevacus represented well at the Capitol! Below is a link to the Senate’s hearing on the subject of brain injury. Our President & Founder, Jake VanLandingham was a member of their expert panel.
What an amazing panel with incredibly impressive testimonials. Such an honor to be a part of this piece of history! http://www.aging.senate.gov/hearings/state-of-play-brain-injuries-and-diseases-of-aging